← Eichor
Study identifier: NCT07039422 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Condition: Primary Immune Thrombocytopenia · Warm Autoimmune Hemolytic Anemia  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 2
Planned participants60
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

This study is intended to explore the efficacy and safety of a second course of ianalumab after experiencing treatment failure in the pivotal Primary Immune Thrombocytopenia (ITP) trials (CVAY736I12301, CVAY736Q12301) and after loss of durable response in the pivotal Warm Autoimmune Hemolytic Anemia (wAIHA) trial (CVAY736O12301).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  1-888-669-6682  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  +41613241111

Always discuss trial participation with your own doctor first.

Locations (25)

Novartis Investigative SiteBuenos Aires, ArgentinaWithdrawn
Novartis Investigative SiteRoeselare, West-Vlaanderen, BelgiumRecruiting
Novartis Investigative SiteGuangzhou, Guangdong, ChinaRecruiting
Novartis Investigative SiteDalian, Liaoning, ChinaRecruiting
Novartis Investigative SiteTianjin, ChinaRecruiting
Novartis Investigative SiteOstrava, Poruba, CzechiaRecruiting
Novartis Investigative SiteCaen, FranceRecruiting
Novartis Investigative SiteRennes, FranceRecruiting
Novartis Investigative SiteJena, Thuringia, GermanyRecruiting
Novartis Investigative SiteDebrecen, Hajdu Bihar Megye, HungaryRecruiting
Novartis Investigative SiteFlorence, FI, ItalyRecruiting
Novartis Investigative SiteRoma, RM, ItalyRecruiting

+ 13 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07039422